Live @ Generator Labs Fall 2017 flier

Download the flier

Entrepreneurship is at your fingertips — all you need to do is start!

The Live @ Generator Lab event series is here to help. On the first and third Thursday from August through November 2017, learn from successful entrepreneurs and startup CEOs, gather with like-minded students to build your venture team and learn new skills to help you on your path to entrepreneurship.

Talk strategy with Dave Brachman

On September 21, Dave Brachman, CEO and CTO of GammaTile Inc, will discuss accidental entrepreneurship, with an emphasis on the need to try to avoid this route whenever possible — unless you just can’t.

Live @ Generator Labs: Grow your startup
Thursday, September 7, 2017
6–8 p.m.
Generator Labs, Engineering Center G-Wing (ECG) 101, Tempe campus [map]
Register to attend this and other Live @ Generator Labs events

You may also participate online via Twitter (@FultonGenLabs) and via YouTube Chat. Check out the live stream and watch any talks you might have missed!

About Dave Brachman

Dave Brachman

Dave Brachman

Dave Brachman is the CEO and CTO of GammaTile Inc., an early stage medical device company located in Phoenix, Arizona, that is focused on the treatment of brain tumors.

In what seems like a lifetime ago, Brachman played a pivotal early role in recognizing and commercializing the hair growth agent now known as Rogaine, and in finding that viruses caused oral cancer (we now have a vaccine for that).

His alter ego is David G Brachman, MD, FACRO, who serves as director of Radiation Oncology at the Barrow Neurological Institute and St. Joseph’s Hospital and Medical Center in Phoenix, and is professor of Radiation Oncology at the University of Arizona College of Medicine-Phoenix. He is a well-published clinical researcher, notably in the field of brain tumors, where he has authored more than 50 peer-reviewed publications.

Prior to coming to Phoenix, Brachman was an internal medicine physician in the Public Health Service and an assistant professor at the University of Chicago where he received his Radiation Oncology training.